The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Network meta-analysis (NMA) to assess comparative efficacy of lenvatinib plus pembrolizumab compared with other first-line treatments for management of advanced renal cell carcinoma (aRCC).
 
Viktor Grünwald
Employment - University Hospital Essen
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; Genmab; MSD; Seagen
Honoraria - Advanced Accelerator Applications/Novartis; Amgen; Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck Serono; MSD Oncology; Nanobiotix; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Cor2Ed; Cureteq; Debiopharm Group; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Oncorena; Onkowissen; PCI Biotech; Pfizer; Synthekine
Research Funding - Amgen (Inst); BMS (Inst); Gilead Sciences (Inst); Ipsen (Inst); MSD Oncology (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Serono; Pfizer
 
Eric Winquist
Consulting or Advisory Role - Bayer; Eisai; EMD Serono; Ipsen; Merck; Roche
Research Funding - Merck (Inst); Roche/Genentech (Inst)
 
Avivit Peer
Honoraria - Astellas Pharma; AstraZeneca; Bayer; BMS; Exelixis; Janssen Oncology; Medison; Merck Serono; MSD; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS; Eisai; Janssen-Cilag; Merck Serono; MSD Oncology; Novartis; Pfizer; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; BMS; MSD; Pfizer
Other Relationship - AstraZeneca
 
Manuela Schmidinger
Honoraria - AstraZeneca; BMS; EISAI; EUSA Pharma; Ipsen; Janssen Oncology; Merck Sharp & Dohme; MSD Oncology
Consulting or Advisory Role - AstraZeneca; BMS; Eisai; EUSA Pharma; Ipsen; MSD Oncology
Research Funding - IPSEN (Inst)
Travel, Accommodations, Expenses - BMS; Ipsen
 
Giuseppe Procopio
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb (BMS); Eisai; Ipsen; Janssen; Merck Sharp & Dohme; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Astellas Pharma; Ipsen; Janssen Oncology
 
Philippe Barthelemy
Honoraria - Astellas Pharma; Bayer; BMS; Gilead Sciences; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer; SEAGEN
Consulting or Advisory Role - AAA/Endocyte/Novartis; Amgen; AstraZeneca; Bayer; BMS; Eisai; Gilead Sciences; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer
Research Funding - IPSEN (Inst)
Travel, Accommodations, Expenses - BMS; IPSEN; Janssen-Cilag; Merck/Pfizer; MSD; Pfizer
 
Jae-Lyun Lee
Stock and Other Ownership Interests - Amgen; Black Diamond Therapeutics; Innovent Biologics; Johnson & Johnson/Janssen; Karyopharm Therapeutics; Merck; Zymeworks
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Merck; Novartis
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca/MedImmune (Inst); Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); GI Innovation (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Oscotec (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Sarah Rudman
Honoraria - IPSEN,; MSD; Pfizer
Speakers' Bureau - Eisai; IPSEN,
Travel, Accommodations, Expenses - IPSEN,
 
Ananth Kadambi
Research Funding - Evidera/PPD (Inst)
 
Anuja Pandey
Research Funding - Evidera/PPD (Inst)
 
Binod Neupane
Research Funding - Evidera/PPD (Inst)
 
Kyle Fahrbach
Research Funding - Evidera (Inst)
 
Sneha Purushotham
Consulting or Advisory Role - Evidera/PPD (Inst)
 
Michael Jones
Research Funding - Evidera/PPD (Inst)
 
Sonya Egodage
Research Funding - Evidera/PPD (Inst)
 
Ananth Kashyap
Research Funding - Evidera (Inst)
 
Wendy Hauck
Employment - Eisai
 
Janice Pan
Employment - Eisai